Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emily Clarke, Jesper Grau Eriksen & Sarah Barrett. (2021) The effects of PD-1/PD-L1 checkpoint inhibitors on recurrent/metastatic head and neck squamous cell carcinoma: a critical review of the literature and meta-analysis. Acta Oncologica 60:11, pages 1534-1542.
Read now
Read now
Reham Ali Dwedar, Noha Mohamed Omar, Somaia Abdel-Latif Eissa, Abdelrahman Younes Aly Badawy, Dalia Abd El-Kareem & Lamiaa Abd El-Fattah Ahmed Madkour. (2020) Diagnostic and prognostic impact of E6/E7 mRNA compared to HPV DNA and p16 expression in head and neck cancers: an Egyptian study. Alexandria Journal of Medicine 56:1, pages 155-165.
Read now
Read now
Lili Ren, Matthias Leisegang, Boya Deng, Tatsuo Matsuda, Kazuma Kiyotani, Taigo Kato, Makiko Harada, Jae-Hyun Park, Vassiliki Saloura, Tanguy Seiwert, Everett Vokes, Nishant Agrawal & Yusuke Nakamura. (2019) Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma. OncoImmunology 8:4.
Read now
Read now
Articles from other publishers (41)
Xiu Hong, Yang Li, Qian Lv, Jun An, Ying Liu, Xiuli Wang, Rui Li, Yuqiang Hu & Bing Liu. (2023) Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma. International Journal of Immunopathology and Pharmacology 37, pages 039463202311720.
Crossref
Crossref
Nicole N. Scheff, Marci L. Nilsen, Jinhong Li, Alexandria L. Harris, Rajesh Acharya, Andrew Swartz, Ronan W Hsieh, Jennifer L. Anderson, Robert L Ferris, Ashley V. Menk, Greg M Delgoffe & Dan P. Zandberg. (2023) The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck. Oral Oncology 140, pages 106363.
Crossref
Crossref
Hao Chi, Xixi Xie, Yingjie Yan, Gaoge Peng, Dorothee Franziska Strohmer, Guichuan Lai, Songyun Zhao, Zhijia Xia & Gang Tian. (2022) Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC. Frontiers in Immunology 13.
Crossref
Crossref
Jerome R. Lechien, Lise Crevier‐Buchman, Lea Distinguin, Giannicola Iannella, Antonino Maniaci, Lisa G. De Marrez, Sven Saussez & Stéphane Hans. (2021) Is Diet Sufficient as Laryngopharyngeal Reflux Treatment? A Cross‐Over Observational Study. The Laryngoscope 132:10, pages 1916-1923.
Crossref
Crossref
Jun Liu, Jianjun Lu & Wenli Li. (2022) Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. BMC Cancer 22:1.
Crossref
Crossref
Brian C. DeFelice, Oliver Fiehn, Peter Belafsky, Constanze Ditterich, Michael Moore, Marianne Abouyared, Angela M. Beliveau, D. Gregory Farwell, Arnaud F. Bewley, Shannon M. Clayton, Joehleen A. Archard, Jordan Pavlic, Shyam Rao, Maggie Kuhn, Peter Deng, Julian Halmai, Kyle D. Fink, Andrew C. Birkeland & Johnathon D. Anderson. (2022) Polyamine Metabolites as Biomarkers in Head and Neck Cancer Biofluids. Diagnostics 12:4, pages 797.
Crossref
Crossref
Guiqin Xie, Liang Shan, Yuanyi Liu, Tzyy-Choou Wu & Xinbin Gu. (2022) Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma. Biology 11:4, pages 486.
Crossref
Crossref
Nikki McCaffrey & Lidia Engel. (2022) Protocol for a systematic review of the financial burden experienced by people affected by head and neck cancer. BMJ Open 12:2, pages e055213.
Crossref
Crossref
Nooshin Mohtasham, Nasrollah Saghravanian, Reza Zare, Shadi Saghafi, Narges Ghazi, Farnaz Mohajertehran & Mehdi Shahabinejad. (2022) Tumor tissue Helicobacter pylori and human papillomavirus infection in head and neck squamous cell carcinoma patients and association with clinicopathological indices: A cross-sectional medical survey. Dental Research Journal 19:1, pages 8.
Crossref
Crossref
Joanna Kałafut, Arkadiusz Czerwonka, Alinda Anameriç, Alicja Przybyszewska-Podstawka, Julia O. Misiorek, Adolfo Rivero-Müller & Matthias Nees. (2021) Shooting at Moving and Hidden Targets—Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas. Cancers 13:24, pages 6219.
Crossref
Crossref
Senthamil R. Selvan, Jennifer A. BrichettiDenise B. ThurberGregory M. BottingGreg P. Bertenshaw. (2021) Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict Cetuximab Response. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Kristen A. Echanique, Lauran K. Evans, Albert Y. Han, Dinesh K. Chhetri & Maie A. St. John. (2021) Cancer of the Larynx and Hypopharynx. Hematology/Oncology Clinics of North America 35:5, pages 933-947.
Crossref
Crossref
Emilia Wiechec, Mustafa Magan, Natasa Matic, Anna Ansell-Schultz, Matti Kankainen, Outi Monni, Ann-Charlotte Johansson & Karin Roberg. (2021) Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma. Cancers 13:13, pages 3361.
Crossref
Crossref
Kun Zhang, Ming Xiao, Xin Jin & Hongyan Jiang. (2021) NR5A2 Is One of 12 Transcription Factors Predicting Prognosis in HNSCC and Regulates Cancer Cell Proliferation in a p53-Dependent Manner. Frontiers in Oncology 11.
Crossref
Crossref
Anne M. van Harten & Ruud H. Brakenhoff. (2021) Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications. Cancers 13:11, pages 2774.
Crossref
Crossref
Jacob H. Rasmussen, Anders B. Olin, Giedrius Lelkaitis, Adam E. Hansen, Flemming L. Andersen, Helle H. Johannesen, Andreas Kjaer, Barbara M. Fischer, Lena Specht, Søren M. Bentzen, Christian von Buchwald, Irene Wessel & Ivan R. Vogelius. (2021) Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma. European Journal of Radiology 139, pages 109668.
Crossref
Crossref
Ashley C. Mays, Bharat Yarlagadda, Virginie Achim, Ryan Jackson, Patrik Pipkorn, Andrew T. Huang, Karthik Rajasekaran, Shaum Sridharan, Andrew J. Rosko, Ryan K. Orosco, Andrew M. Coughlin, Mark K. Wax, Yelizaveta Shnayder, William C. Spanos, Donald Gregory Farwell, Lee S. McDaniel & Matthew M. Hanasono. (2021) Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer. Head & Neck 43:5, pages 1509-1520.
Crossref
Crossref
Julia Ingruber, Dragana Savic, Teresa Bernadette Steinbichler, Susanne Sprung, Felix Fleischer, Rudolf Glueckert, Gabriele Schweigl, Ira-Ida Skvortsova, Herbert Riechelmann & József Dudás. (2021) KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma. Cells 10:3, pages 539.
Crossref
Crossref
Yixiao Qin, Xiwang Zheng, Wei Gao, Binquan Wang & Yongyan Wu. (2021) Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma. Molecular Therapy - Oncolytics 20, pages 342-351.
Crossref
Crossref
Christopher Bockhorst, Jörn Dietrich, Timo J Vogt, Roland H Stauber, Sebastian Strieth, Friedrich Bootz, Dimo Dietrich & Luka de Vos. (2021)
The DNA methylation landscape of
PD-1
(
PDCD1
) and adjacent lncRNA
AC131097.3
in head and neck squamous cell carcinoma
. Epigenomics 13:2, pages 113-127.
Crossref
Crossref
Daniel Troeltzsch, Stefan Markus Niehues, Tabea Fluegge, Norbert Neckel, Max Heiland, Bernd Hamm & Seyd Shnayien. (2020) The diagnostic performance of perfusion CT in the detection of local tumor recurrence in head and neck cancer. Clinical Hemorheology and Microcirculation 76:2, pages 171-177.
Crossref
Crossref
Maria Cilona, Luca Giovanni Locatello, Luca Novelli & Oreste Gallo. (2020) The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review. Cancers 12:10, pages 3006.
Crossref
Crossref
Mengqi Huo, Ying Zhang, Zhong Chen, Suxin Zhang, Yang Bao & Tianke Li. (2020) Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures. Scientific Reports 10:1.
Crossref
Crossref
Samantha M. Y. Chen, Alexandra L. Krinsky, Rachel A. Woolaver, Xiaoguang Wang, Zhangguo Chen & Jing H. Wang. (2020) Tumor immune microenvironment in head and neck cancers. Molecular Carcinogenesis 59:7, pages 766-774.
Crossref
Crossref
Sarek Shen, Yuki Saito, Shuling Ren, Chao Liu, Theresa Guo, Jesse Qualliotine, Zubair Khan, Sayed Sadat & Joseph A. Califano. (2020) Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV‐Positive Oropharyngeal Cancer. Otolaryngology–Head and Neck Surgery 162:4, pages 512-519.
Crossref
Crossref
J Gowthami, N Gururaj, V Mahalakshmi, R Sathya, TR Sabarinath & DaffneyMano Doss. (2020) Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review. Journal of Oral and Maxillofacial Pathology 24:2, pages 293.
Crossref
Crossref
Jerome R. Lechien, Francois Bobin, Francois Mouawad, Karol Zelenik, Christian Calvo-Henriquez, Carlos M. Chiesa-Estomba, Necati Enver, Andrea Nacci, Maria Rosaria Barillari, Antonio Schindler, Lise Crevier-Buchman, Stéphane Hans, Virginie Simeone, Elzbieta Wlodarczyk, Bernard Harmegnies, Marc Remacle, Alexandra Rodriguez, Didier Dequanter, Pierre Eisendrath, Giovanni Dapri, Camille Finck, Petros Karkos, Hillevi Pendleton, Tareck Ayad, Vinciane Muls & Sven Saussez. (2019) Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux. European Archives of Oto-Rhino-Laryngology 276:12, pages 3389-3404.
Crossref
Crossref
Khalil Saleh, Amaury Daste, Nicolas Martin, Elvire Pons-Tostivint, Anne Auperin, Ruth Gabriela Herrera-Gomez, Neus Baste-Rotllan, Francois Bidault, Joel Guigay, Christophe Le Tourneau, Esma Saada-Bouzid & Caroline Even. (2019) Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer 121, pages 123-129.
Crossref
Crossref
Mohamed Badr, Korinna Jöhrens, Michael Allgäuer, Melanie Boxberg, Wilko Weichert, Ingeborg Tinhofer, Carsten Denkert, Peter Schirmacher, Albrecht Stenzinger & Jan Budczies. (2019) Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer. Cancer Immunology, Immunotherapy 68:9, pages 1443-1454.
Crossref
Crossref
Tyler Tabares, Todd Unmack, Mary Calys & Lisa Stehno-Bittel. (2019) New Anticancer Immunotherapies: Implications for Physical Therapy. Rehabilitation Oncology 37:3, pages 128-137.
Crossref
Crossref
Hong Zhou, Ting Cao, Wen Ping Li & Gang Wu. (2019) Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma. Molecular Biology Reports 46:3, pages 2693-2701.
Crossref
Crossref
Donald T. Weed, Serena Zilio, Isildinha M. Reis, Zoukaa Sargi, Marianne Abouyared, Carmen R. Gomez-Fernandez, Francisco J. Civantos, Carla P. Rodriguez & Paolo Serafini. (2019) The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial. Frontiers in Immunology 10.
Crossref
Crossref
Natalie Wolkow, Frederick A. Jakobiec, Amir H. Afrogheh, Ralph C. EagleJr.Jr., Sara I. Pai & William C. Faquin. (2019) Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications. American Journal of Ophthalmology 200, pages 226-241.
Crossref
Crossref
Anna V. Kudryavtseva, Elena N. Lukyanova, Dmitry V. Kalinin, Andrew R. Zaretsky, Anatoly V. Pokrovsky, Alexander L. Golovyuk, Maria S. Fedorova, Elena A. Pudova, Sergey L. Kharitonov, Vladislav S. Pavlov, Anastasiya A. Kobelyatskaya, Nataliya V. Melnikova, Alexey A. Dmitriev, Andrey P. Polyakov, Boris Y. Alekseev, Marina V. Kiseleva, Andrey D. Kaprin, George S. Krasnov & Anastasiya V. Snezhkina. (2019) Mutational load in carotid body tumor. BMC Medical Genomics 12:S2.
Crossref
Crossref
József Dudás, Anna Riml, Raphaela Tuertscher, Christian Pritz, Teresa Steinbichler, Volker Schartinger, Susanne Sprung, Rudolf Glueckert, Anneliese Schrott-Fischer, Lejo Johnson Chacko & Herbert Riechelmann. (2019) Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences 20:2, pages 272.
Crossref
Crossref
S. Deneuve. 2019. Cancers du Larynx. Cancers du Larynx
65
74
.
Jennifer A. Bridge, James C. Lee, Adil Daud, James W. Wells & Jeffrey A. Bluestone. (2018) Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer. Frontiers in Medicine 5.
Crossref
Crossref
Cassie Pan, Natalia Issaeva & Wendell G. Yarbrough. (2018) HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis. Cancers of the Head & Neck 3:1.
Crossref
Crossref
Zihai Li, Wenru Song, Mark Rubinstein & Delong Liu. (2018) Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Cong-Cong Wu, Hao Li, Yao Xiao, Lei-Lei Yang, Lei Chen, Wei-Wei Deng, Lei Wu, Wen-Feng Zhang & Zhi-Jun Sun. (2018) Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma. Journal of Molecular Histology 49:4, pages 389-398.
Crossref
Crossref
József Dudás, Wolfgang Dietl, Angela Romani, Susanne Reinold, Rudolf Glueckert, Anneliese Schrott-Fischer, Daniel Dejaco, Lejo Johnson Chacko, Raphaela Tuertscher, Volker Schartinger & Herbert Riechelmann. (2018) Nerve Growth Factor (NGF)—Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences 19:6, pages 1771.
Crossref
Crossref